Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed full pipeline small index

Intra-abdominal Infection: full-pipeline trial registry

A small indexed set (2 trials) with no open enrollment listed right now.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count

Intra-abdominal Infection: 2 US clinical trials tracked, none currently recruiting.

Intra-abdominal Infection is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is The Emmes Company, running 1 of these trials.

Enrollment posture brief

Registry condition intra-abdominal-infection

OPEN 0 | RECR 0% | LATE 1 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Intra-abdominal Infectio (th…0%
Open-enrollment share among volume-matched conditions near Intra-abdominal Infection

Intra-abdominal Infection has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Intra-abdominal Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Intra-abdominal Infection is recruiting below its size-band peers.

    0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 41

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 4 1

Top Sponsors

Named interventions

Most-linked intervention names on Intra-abdominal Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

meropenem Drug
1 trials
Nutrition Ecosystem pathway Combination
1 trials
Comparator Other
1 trials

US sites by state

Facility locations filed on Intra-abdominal Infection trials. A trial with sites in several states counts in each.

North Carolina 2 trials
Ohio 1 trials
New York 1 trials
Missouri 1 trials
Michigan 1 trials
Kentucky 1 trials
Indiana 1 trials
Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Intra-abdominal Infection page

2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Intra-abdominal Infection trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • The Emmes Company sponsors the most Intra-abdominal Infection trials on record, review their full trial history before evaluating a specific study. See The Emmes Company's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Intra-abdominal Infection condition card totals 2 registered trials; most-linked intervention meropenem; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.